Table 2 Single dose pharmacokinetics of nirmatrelvir/ritonavir in ferret and human plasma

From: Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models

Drug

Species

Dose (mg/kg)

Tmax (h)

Cmax (ng/ml)

AUCinf (hours × ng/ml)

t1/2 (h)

Reference

Nirmatrelvir/ritonavir

Ferret

20/6

2.33

8990

32,700

1.05

This study

Nirmatrelvir/ritonavir

Ferret

100/6

4

11,800

49,500

0.74

This study

Nirmatrelvir/ritonavir

Human

250/100a

2.75

2882

28,220

6.94

34

Molnupiravir

Human

800a

1.75

2770

8200

1.18

36

Molnupiravir

Ferret

4

1.7

907

3421

8.2

33

Molnupiravir

Ferret

7

1.5

2851

7569

9.2

33

Molnupiravir

Ferret

20

1.8

3992

18,793

4.7

33

Molnupiravir

Macaque

130

1.62

2644

25,299

1.77

33

  1. aHuman doses are expressed as absolute amount, not mg/kg.